Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholang...

由 Chiu, Tai-Jan, Chen, Yi-Ju, Kuo, Fang-Ying, Chen, Yen-Yang
發表在 PLoS One (2020)

Clinical impact of lenvatinib in patients with unresectable hepatocellular carcinoma who received sorafenib

由 Chen, Yen-Yang, Wang, Chih-Chi, Liu, Yueh-Wei, Li, Wei-Feng, Chen, Yen-Hao
發表在 PeerJ (2020)

Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder

由 Hsieh, Meng-Che, Huang, Cheng-Hua, Chiang, Po-Hui, Chen, Yen-Yang, Tang, Yeh, Su, Yu-Li
發表在 J Cancer (2016)

Incidence, Risk Factors, and Outcomes of Arterial Thromboembolism in Patients with Pancreatic Cancer Following Palliative Chemotherapy

由 Hung, Yu-Shin, Chen, Jen-Shi, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Chou, Wen-Chi
發表在 Cancers (Basel) (2018)

Evolution of the chemotherapeutic landscape and survival outcome in patients with metastatic pancreatic cancer: a four-institute cohort study in Taiwan, 2010–2016

由 Chou, Wen-Chi, Chen, Yen-Yang, Hung, Chia-Yen, Chen, Jen-Shi, Lu, Chang-Hsien, Chang, Pei-Hung
發表在 Cancer Manag Res (2019)

Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

由 Chen, Yen-Yang, Yeh, Chun-Nan, Cheng, Chi-Tung, Chen, Tsung-Wen, Rau, Kun-Ming, Jan, Yi-Yin, Chen, Miin-Fu
出版 2011

Pegylated liposomal doxorubicin (Lipo-Dox®) combined with cyclophosphamide and 5-fluorouracil is effective and safe as salvage chemotherapy in taxane-treated metastatic breast canc...

由 Rau, Kun-Ming, Lin, Yung-Chang, Chen, Yen-Yang, Chen, Jen-Shi, Lee, Kuan-Der, Wang, Cheng-Hsu, Chang, Hsien-Kun
發表在 BMC Cancer (2015)

The efficacy and toxicity of adjuvant S-1 schedule with 2-week administration followed by 1-week rest in gastric cancer patients

由 Liu, Yu-Yin, Liu, Yueh-Wei, Chen, Yen-Yang, Wang, Shih-Ho, Chuah, Seng-Kee, Huang, Gong-Kai, Chen, Yen-Hao
發表在 J Gastrointest Oncol (2021)

Presence of Chronic Obstructive Pulmonary Disease (COPD) Impair Survival in Lung Cancer Patients Receiving Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI): A...

由 Wu, Chia-Che, Rau, Kun-Ming, Lee, Wei-Chieh, Hsieh, Meng-Che, Liu, Jia-Sin, Chen, Yen-Yang, Su, Harvey Yu-Li
發表在 J Clin Med (2019)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma

由 Ma, Ming-Chun, Chen, Yi-Ju, Chiu, Tai-Jan, Lan, Jui, Liu, Chien-Ting, Chen, Yi-Ching, Tien, Hsin-Ho, Chen, Yen-Yang
發表在 BMC Cancer (2018)

Neovascularization evaluated by CD105 correlates well with prognostic factors in breast cancers

由 RAU, KUN-MING, HUANG, CHAO-CHENG, CHIU, TAI-JAN, CHEN, YEN-YANG, LU, CHIEN-CHANG, LIU, CHIEN-TING, PEI, SUNG-NAN, WEI, YU-CHING
出版 2012

PLCB4 copy gain and PLCß4 overexpression in primary gastrointestinal stromal tumors: Integrative characterization of a lipid-catabolizing enzyme associated with worse disease-free...

由 Li, Chien-Feng, Liu, Ting-Ting, Chuang, I-Chieh, Chen, Yen-Yang, Fang, Fu-Min, Chan, Ti-Chun, Li, Wan-Shan, Huang, Hsuan-Ying
發表在 Oncotarget (2017)

A phase II trial of regorafenib in patients with metastatic and/or a unresectable gastrointestinal stromal tumor harboring secondary mutations of exon 17

由 Yeh, Chun-Nan, Chen, Ming-Huang, Chen, Yen-Yang, Yang, Ching-Yao, Yen, Chueh-Chuan, Tzen, Chin-Yuan, Chen, Li-Tzong, Chen, Jen-Shi
發表在 Oncotarget (2017)

Hydroxysteroid 11-Beta Dehydrogenase 1 Overexpression with Copy-Number Gain and Missense Mutations in Primary Gastrointestinal Stromal Tumors

由 Li, Chien-Feng, Liu, Ting-Ting, Wang, Jui-Chu, Yu, Shih-Chen, Chen, Yen-Yang, Fang, Fu-Min, Li, Wan-Shan, Huang, Hsuan-Ying
發表在 J Clin Med (2018)

Prognostic Factors for Advanced Pancreatic Cancer Treated with Gemcitabine Plus S-1: Retrospective Analysis and Development of a Prognostic Model

由 Chang, Ching-Fu, Huang, Pei-Wei, Chen, Jen-Shi, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Hung, Yu-Shin, Chou, Wen-Chi
發表在 Cancers (Basel) (2019)

S-1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection—A Propensity Score Matching Analysis

由 Hsieh, Meng-Che, Wang, Shih-Ho, Wei, Ching-Ting, Chen, Chung-Yen, Chen, Yen-Yang, Pei, Sung-Nan, Tsai, Yu-Fen, Rau, Kun-Ming
發表在 Cancers (Basel) (2020)

Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1–2 tumor and 1–3 axillary lymph node(s) metastasis

由 Su, Yu-Li, Li, Shan-Hsuan, Chen, Yen-Yang, Chen, Hui-Chun, Tang, Yen, Huang, Cheng-Hua, Chou, Fong-Fu, Wu, Shih-Chung, Rau, Kun-Ming
出版 2014

Venous Thromboembolism in Asian Patients with Pancreatic Cancer Following Palliative Chemotherapy: Low Incidence but a Negative Prognosticator for Those with Early Onset

由 Chen, Jen-Shi, Hung, Chia-Yen, Chang, Hung, Liu, Chien-Ting, Chen, Yen-Yang, Lu, Chang-Hsien, Chang, Pei-Hung, Hung, Yu-Shin, Chou, Wen-Chi
發表在 Cancers (Basel) (2018)

Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan

由 Yeh, Chun-Nan, Chen, Yen-Yang, Tseng, Jeng-Hwei, Chen, Jen-Shi, Chen, Tsung-Wen, Tsai, Chun-Yi, Cheng, Chi-Tung, Jan, Yi-Yin, Chen, Miin-Fu
出版 2011

Fractioned Dose Regimen of Sunitinib for Patients with Gastrointestinal Stromal Tumor: A Pharmacokinetic and Treatment Efficacy Study()

由 Chen, Yen-Yang, Yeh, Chun-Nan, Cheng, Chi-Tung, Wu, Chao-En, Chiang, Kun-Chun, Chen, Tsung-Wen, Wang, Chih-Chi, Chen, Jen-Shi, Yeh, Ta-Sen
發表在 Transl Oncol (2014)